BD² Updates
BD² Celebrates International Day of Women and Girls in Science
Women and girls play a critical role in unlocking answers to some of the world’s most pressing scientific questions, but inequalities and barriers continue to pose challenges to participation in STEM. Only through diversity in all areas of science—from study participants to clinicians, researchers, and leadership—can there be a truly inclusive, prosperous, and sustainable world. …
Read more
BD² in Bipolar Disorders Journal
What could supercharged collaboration mean for bipolar disorder research? Read more from BD² Managing Director, Cara Altimus, PhD, BD² program directors, and Scientific Steering Committe chairs. Bipolar Disorders Journal: Supercharging collaboration for bipolar research—Breakthrough discoveries for thriving with bipolar disorder (BD²) “The field needs both more dedicated funding and infrastructure to bring together researchers, clinicians, and …
Read more
2023 Milestones
Since publicly launching just over a year ago, we’ve built a connected network of 100+ scientists and clinicians, awarded more than $60 million in grants, launched first-of-its-kind research for bipolar disorder across our programs, and more. Our work continues to be driven by our commitment to removing silos, building foundational knowledge, and accelerating the translation …
Read more
BD² Announces Research and Clinical Network to Advance Treatment for Bipolar Disorder
Washington, DC – BD²: Breakthrough Discoveries for thriving with Bipolar Disorder today announced the first six institutions that will launch the groundbreaking BD² Integrated Network. Brigham and Women’s Hospital-McLean Hospital, University of California Los Angeles, Johns Hopkins University, Mayo Clinic, University of Michigan, and UTHealth Houston together comprise the first sites that will work in …
Read more
BD² Announces $18 Million in Grants to Understand Biology of Bipolar Disorder
Washington, D.C. – BD²: Breakthrough Discoveries for thriving with Bipolar Disorder today announced its first round of Discovery Research grants, totaling $18 million, bringing greater collaboration and focused funding to the field of bipolar disorder. Multidisciplinary teams of scientists and clinicians, whose leads are at Yale University, Stanford University, New York Genome Center, and the …
Read more
BD² in JAMA Medical News
Bipolar disorder is difficult to both diagnose and treat. The disorder is characterized by a range of symptoms including hypomania and depression that vary from patient to patient, and effective medical treatment is often only found after patients try multiple ineffective treatments. JAMA Medical News details how BD² is working to better understand the genetic …
Read more
BD² Announces First $15 Million in Grants to Advance Genetic and Biological Understanding of Bipolar Disorder
Washington, D.C. – March 30, 2023 – BD²: Breakthrough Discoveries for thriving with Bipolar Disorder today announced its first grants, totaling $15 million, to advance scientific understanding of the genetic and biological foundations of bipolar disorder. These first-of-their-kind efforts aim to accelerate discovery and improve diagnosis and care for the more than 40 million people …
Read more
Why Three Deep-Pocketed Funders Joined Forces to Take on Bipolar Disorder
Source: Paul Karon, Inside Philanthropy Among serious forms of mental illness, bipolar disorder has been one of the least-funded in terms of research. In fact, it’s seen sharply diminishing support in recent years, even as federal funding for other forms of mental illness has increased. That has left the estimated 40 million people worldwide who …
Read more